ALK-rearrangement has been recently described by Hamatani et al. [50] in 10 of 19 patients (atomic bomb survivors) with radiation exposed papillary thyroid carcinoma, with no detectable gene alterations in BRAF, RET, NTRK1, or RAS. This evidence concerns the gene BRAF and differentiated thyroid carcinoma.